Candoxatril
CAS No. 123122-55-4
Candoxatril( UK 79300 )
Catalog No. M10912 CAS No. 123122-55-4
The orally active prodrug of candoxatrilat (UK-73967), potent neutral endopeptidase EC 3.4.24.11 (atriopeptidase) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 873 | In Stock |
|
50MG | 1782 | In Stock |
|
100MG | 2250 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCandoxatril
-
NoteResearch use only, not for human use.
-
Brief DescriptionThe orally active prodrug of candoxatrilat (UK-73967), potent neutral endopeptidase EC 3.4.24.11 (atriopeptidase) inhibitor.
-
DescriptionThe orally active prodrug of candoxatrilat (UK-73967), potent neutral endopeptidase EC 3.4.24.11 (atriopeptidase) inhibitor.Heart Failure Discontinued.
-
In Vitro——
-
In VivoWhile the NEP inhibitors have no significant effect on body weight, food and water intake, mean blood pressure or creatinine levels, they do increase cGMP levels in the urine and affected hematopoiesis in an anti-inflammatory way. Moreover, a-SMA deposition in the kidney cortex is inversely correlated with cGMP elevation suggesting a NEP dependent antifibroti effect. High quality mRNA profiles are obtained with at least 8 independent samples per treatment group. The data confirms the cGMP dependent anti-fibrotic action of Sol-1 and further supports the potential therapeutic actions of this neutral endopeptidase inhibitor.
-
SynonymsUK 79300
-
PathwayMetabolic Enzyme/Protease
-
TargetNeprilysin
-
RecptorNeprilysin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number123122-55-4
-
Formula Weight515.638
-
Molecular FormulaC29H41NO7
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOCCOCC(CC1(CCCC1)C(=O)NC2CCC(CC2)C(=O)O)C(=O)OC3=CC4=C(CCC4)C=C3
-
Chemical Name4-{[(1-{3-(2,3-dihydro-1H-inden-5-yloxy)-2-[(2-methoxyethoxy)methyl]-3-oxopropyl}cyclopentyl)carbonyl]amino}cyclohexanecarboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Danilewicz JC, et al. Biochem Biophys Res Commun. 1989 Oct 16;164(1):58-65.
2. Shepperson NB, et al. Br J Pharmacol. 1989 Dec;98 Suppl:822P.
3. Jardine AG, et al. Am J Hypertens. 1990 Sep;3(9):661-7.
4. Northridge DB, et al. Lancet. 1989 Sep 9;2(8663):591-3.
molnova catalog
related products
-
LHW090-A7
LHW090-A7 is an neutral endopeptidase (NEP) inhibitor, and an enzyme responsible for the metabolic inactivation of enkephalins.
-
Candoxatril
The orally active prodrug of candoxatrilat (UK-73967), potent neutral endopeptidase EC 3.4.24.11 (atriopeptidase) inhibitor.
-
LCZ-696
A novel single molecule comprising molecular moieties of valsartan and NEP inhibitor prodrug AHU377.